Insmed | INSM - Equity Capital And Reserves

Stock Price
155.27
Daily Change
2.83 1.86%
Monthly
-11.31%
Yearly
92.21%
Q1 Forecast
152.04

Insmed reported $945.57M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
BioMarin Pharmaceutical USD 6.06B 29.6M Sep/2025
Cytokinetics USD -521.12M 216.32M Sep/2025
DBV Technologies USD 52.85M 33.37M Sep/2025
Dynavax Technologies USD 534.14M 39.98M Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
Insmed USD 945.57M 304.16M Sep/2025
Novartis USD 44.33B 2.28B Sep/2025
Regeneron Pharmaceuticals USD 31.26B 299.1M Dec/2025
Sarepta Therapeutics USD 1.32B 37.26M Sep/2025
Ultragenyx Pharmaceutical USD 9.16M 142.13M Sep/2025
Vertex Pharmaceuticals USD 17.32B 143.4M Sep/2025